Denver
Utsunomiya-Mobile

Primary Hyperoxaluria Type 1 (PH1)

American Society of Nephrology (ASN) 2026

Congress Details

calanderOctober 21-25, 2026

locationDenver, CO, USA

The material below is provided to support scientific exchange and pertains to select congress resources. Any content about investigational therapeutics or investigational uses of locally approved products does not establish the safety or efficacy of these therapeutics or uses, and there is no guarantee of local regulatory approval.

All congress materials are copyrighted by Alnylam. Permission is required to copy or distribute.

For questions beyond a product’s authorized indications or for information not available here, please contact Alnylam Medical Information.

Oral

Agenda

Coming soon
icon Presentation Type
Poster Presentation
time icon Time
10:00 - 12:00 MST
location icon Location
Exhibit Hall A Poster board: SA-PO0173
icon Title
Long-Term Lumasiran in a Subset of Patients Who Underwent Isolated Kidney Transplant: Data from ILLUMINATE-C
mic Presenter

Mini Michael
Texas Children's Hospital, Houston, Texas, United States

Coming soon
icon Presentation Type
Poster Presentation
time icon Time
10:00 - 12:00 MST
location icon Location
Exhibit Hall A Poster board: SA-PO0174
icon Title
Baseline Urinary Oxalate and Lumasiran Treatment Response in the ILLUMINATE-A Study
mic Presenter

David J. Sas
Mayo Clinic, Rochester, Minnesota, United States

Related Materials

Primary Hyperoxaluria Type 1 (PH1)

Reducing diagnostic delays in acute hepatic porphyria using health records data and machine learning

Journal of the American Medical Informatics Association

Author(s)

Balu Bhasuran, Katharina Schmolly, Yuvraaj Kapoor, et al

July 2024

Primary Hyperoxaluria Type 1 (PH1)

Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1: Results from a Phase III Clinical Trial

Kidney International Reports

Author(s)

Jeffrey M. Saland, John C. Lieske, Jaap W. Groothoff, et al

April 2024

Primary Hyperoxaluria Type 1 (PH1)

Distinguishing characteristics of pediatric patients with primary hyperoxaluria type 1 in PEDSnet

Journal of Pediatric Urology

Author(s)

Gregory E. Tasian, Kimberley Dickinson, Grace Park, et al

February 2024

Primary Hyperoxaluria Type 1 (PH1)

Qualitative assessment of the patient experience of primary hyperoxaluria type 1: an observational study

BMC Nephrology

Author(s)

David Danese, Diana Goss, Carla Romano, et al

October 2023

Primary Hyperoxaluria Type 1 (PH1)

Quantification of oxalate by novel LC-MS/MS: assay development, validation and application in lumasiran clinical trials

Bioanalysis

Author(s)

Valerie A Clausen, Karen H Cao, John M Gansner, et al

May 2023

Primary Hyperoxaluria Type 1 (PH1)

Estimating health state utilities in primary hyperoxaluria type 1: a valuation study

Journal of Medical Economics

Author(s)

Hayley M de Freitas, David Danese, Lena Hubig, et al

March 2023